🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Global Phase 2 Study to Evaluate the Efficacy and Safety of ARX788 for Se...
Status
Withdrawn
Location
Mount Sinai Medical Center
Start Date
2021-11-05
Trial ID
NCT05041972
Treatments Being Tested
This phase II trial tests how well ARX788 works in treating patients diagno...
Status
Recruiting
Location
University of California, San Francisco
Start Date
2026-06-05
Trial ID
NCT06224673
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
This is a randomized, open label Phase II-III neoadjuvant study comparing t...
Status
Active Not Recruiting
Location
Shengjing Hospital affiliated to China Medical University
Start Date
2022-05-23
Trial ID
NCT05426486
Treatments Being Tested
A Phase 2 Study of ARX788 in unresectable and/or metastatic breast cancer w...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-10-20
Trial ID
NCT05018676
Treatments Being Tested
A single arm, phase 2 Study of ARX788 in HER2-positive metastatic breast ca...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-09-30
Trial ID
NCT06578286
Treatments Being Tested
A Phase 2 Study of ARX788 in HER2-positive, Metastatic Breast Cancer Patien...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-07-14
Trial ID
NCT05018702
Treatments Being Tested
Next-generation Site-specific human epidermal growth factor receptor 2 (HER...
Status
Recruiting
Location
Shengjing Hospital affiliated to China Medical University
Start Date
2021-08-01
Trial ID
NCT04983121
This 2-part, Phase 1, open-label study will determine the recommended Phase...
Status
Completed
Location
USC Norris Cancer Hospital
Start Date
2018-03-20
Trial ID
NCT03255070
Treatments Being Tested
This is a 2-part, Phase 1 FIH study with Phase 1a designed to determine the...
Status
Terminated
Location
Mater Adult Hospital
Start Date
2016-03
Trial ID
NCT02512237
Treatments Being Tested